Anatomic Neuroimaging Characteristics of Posterior Fossa Type A Ependymoma Subgroups

References

1. 1.↵
   1. Ostrom QT,
   2. Patil N,
   3. Cioffi G, et al

   . CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. Neuro Oncol 2020;22:iv1–96 doi:10.1093/neuonc/noaa200 pmid:33123732

   CrossRefPubMed
2. 2.↵
   1. Zhang C,
   2. Ostrom QT,
   3. Semmes EC, et al

   ; Glioma International Case-Control Study (GICC). Genetic predisposition to longer telomere length and risk of childhood, adolescent and adult-onset ependymoma. Acta Neuropathol Commun 2020;8:173 doi:10.1186/s40478-020-01038-w pmid:33115534

   CrossRefPubMed
3. 3.↵
   1. Vaidya K,
   2. Smee R,
   3. Williams JR

   . Prognostic factors and treatment options for paediatric ependymomas. J Clin Neurosci 2012;19:1228–35 doi:10.1016/j.jocn.2012.02.006 pmid:22840355

   CrossRefPubMed
4. 4.↵
   1. Sabin ND,
   2. Merchant TE,
   3. Li X, et al

   . Quantitative imaging analysis of posterior fossa ependymoma location in children. Childs Nerv Syst 2016;32:1441–47 doi:10.1007/s00381-016-3092-4 pmid:27117266

   CrossRefPubMed
5. 5.↵
   1. Sanford RA,
   2. Merchant TE,
   3. Zwienenberg-Lee M, et al

   . Advances in surgical techniques for resection of childhood cerebellopontine angle ependymomas are key to survival. Childs Nerv Syst 2009;25:1229–40 doi:10.1007/s00381-009-0886-7 pmid:19484252

   CrossRefPubMed
6. 6.↵
   1. Gajjar A,
   2. Robinson GW,
   3. Smith KS, et al

   . Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an International Phase III Trial (SJMB03). J Clin Oncol 2021;39:822–35 doi:10.1200/JCO.20.01372 pmid:33405951

   CrossRefPubMed
7. 7.↵
   1. Juraschka K,
   2. Taylor MD

   . Medulloblastoma in the age of molecular subgroups: a review. J Neurosurg Pediatr 2019;24:353–63 doi:10.3171/2019.5.PEDS18381 pmid:31574483

   CrossRefPubMed
8. 8.↵
   1. Malbari F,
   2. Lindsay H

   . Genetics of common pediatric brain tumors. Pediatr Neurol 2020;104:3–12 doi:10.1016/j.pediatrneurol.2019.08.004 pmid:31948735

   CrossRefPubMed
9. 9.↵
   1. Pajtler KW,
   2. Wen J,
   3. Sill M, et al

   . Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas. Acta Neuropathol 2018;136:211–26 doi:10.1007/s00401-018-1877-0 pmid:29909548

   CrossRefPubMed
10. 10.↵
    1. Pajtler KW,
    2. Witt H,
    3. Sill M, et al

    . Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 2015;27:728–43 doi:10.1016/j.ccell.2015.04.002 pmid:25965575

    CrossRefPubMed
11. 11.↵
    1. Louis DN,
    2. Perry A,
    3. Wesseling P, et al

    . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23:1231–51 doi:10.1093/neuonc/noab106 pmid:34185076

    CrossRefPubMed
12. 12.↵
    1. Gibson P,
    2. Tong Y,
    3. Robinson G, et al

    . Subtypes of medulloblastoma have distinct developmental origins. Nature 2010;468:1095–99 doi:10.1038/nature09587 pmid:21150899

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Ly KI,
    2. Wen PY,
    3. Huang RY

    . Imaging of central nervous system tumors based on the 2016 World Health Organization Classification. Neurol Clin 2020;38:95–113 doi:10.1016/j.ncl.2019.08.004 pmid:31761063

    CrossRefPubMed
14. 14.↵
    1. Patay Z,
    2. DeSain LA,
    3. Hwang SN, et al

    . MR imaging characteristics of wingless-type-subgroup pediatric medulloblastoma. AJNR Am J Neuroradiol 2015;36:2386–93 doi:10.3174/ajnr.A4495 pmid:26338912

    Abstract/FREE Full Text
15. 15.↵
    1. Perreault S,
    2. Ramaswamy V,
    3. Achrol AS, et al

    . MRI surrogates for molecular subgroups of medulloblastoma. AJNR Am J Neuroradiol 2014;35:1263–69 doi:10.3174/ajnr.A3990 pmid:24831600

    Abstract/FREE Full Text
16. 16.↵
    1. Yonezawa U,
    2. Karlowee V,
    3. Amatya VJ, et al

    . Radiology profile as a potential instrument to differentiate between posterior fossa ependymoma (PF-EPN) group A and B. World Neurosurg 2020;140:e320–27 doi:10.1016/j.wneu.2020.05.063 pmid:32428725

    CrossRefPubMed
17. 17.↵
    1. Ikezaki K,
    2. Matsushima T,
    3. Inoue T, et al

    . Correlation of microanatomical localization with postoperative survival in posterior fossa ependymomas. Neurosurgery 1993;32:38–44 doi:10.1227/00006123-199301000-00006 pmid:8421555

    CrossRefPubMed
18. 18.↵
    1. U-King-Im JM,
    2. Taylor MD,
    3. Raybaud C

    . Posterior fossa ependymomas: new radiological classification with surgical correlation. Childs Nerv Syst 2010;26:1765–72 doi:10.1007/s00381-010-1251-6 pmid:20680298

    CrossRefPubMed
19. 19.↵
    1. Ma SC,
    2. Li CD,
    3. Agazzi S, et al

    . Clinical characteristics and prognostic factors of treatment in pediatric posterior cranial fossa ependymoma. Pediatr Neurosurg 2019;54:98–107 doi:10.1159/000495809 pmid:30699434

    CrossRefPubMed
20. 20.↵
    1. Pearson H,
    2. Stirling D

    . DNA extraction from tissue. Methods Mol Biol 2003;226:33–4 doi:10.1385/1-59259-384-4:33 pmid:12958476

    CrossRefPubMed
21. 21.↵
    1. Capper D,
    2. Jones DTW,
    3. Sill M, et al

    . DNA methylation-based classification of central nervous system tumours. Nature 2018;555:469–74 doi:10.1038/nature26000 pmid:29539639

    CrossRefPubMed
22. 22.↵
    1. Nagib MG,
    2. O'Fallon MT

    . Posterior fossa lateral ependymoma in childhood. Pediatr Neurosurg 1996;24:299–305 doi:10.1159/000121059 pmid:8988495

    CrossRefPubMed
23. 23.↵
    1. Witt H,
    2. Mack SC,
    3. Ryzhova M, et al

    . Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 2011;20:143–57 doi:10.1016/j.ccr.2011.07.007 pmid:21840481

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Iv M,
    2. Zhou M,
    3. Shpanskaya K, et al

    . MR imaging-based radiomic signatures of distinct molecular subgroups of medulloblastoma. AJNR Am J Neuroradiol 2019;40:154–61 doi:10.3174/ajnr.A5899 pmid:30523141

    Abstract/FREE Full Text
25. 25.↵
    1. Yan J,
    2. Liu L,
    3. Wang W, et al

    . Radiomic features from multi-parameter MRI combined with clinical parameters predict molecular subgroups in patients with medulloblastoma. Front Oncol 2020;10:558162 doi:10.3389/fonc.2020.558162 pmid:33117690

    CrossRefPubMed